BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. The company is headquartered in Mumbai, Maharashtra. The company is also involved in the manufacturing of therapeutic formulations. The company offers a range of oral solid dosages (OSD) technologies. The company offers its products in various therapeutic classes, such as antifungal, antibiotics, anticancer, anti-diabetic, antidepressant, anti-ulcerant, antimalarial, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, non-steroidal anti-inflammatory drugs, psychotropic, trichology, and vitamins and minerals. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow-Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg and Indomethacin Extended-Release Capsules U.S.P. 75 mg.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.